[ad_1] AstraZeneca PLC said Monday that its Forxiga drug has been recommended for approval in…
Biopharmaceuticals
-
-
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for…
-
STOCK MARKET
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
by userby user[ad_1] Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday,…
-
STOCK MARKET
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio
by userby user[ad_1] Amgen Inc. said Monday that it’s acquiring Dublin-based Horizon Therapeutics in a roughly $28…
-
[ad_1] Danish biotechnology companies Novozymes AS NZYM.B, -13.36% and Chr. Hansen Holding AS CHR, +23.91%…
-
[ad_1] Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the…
-
STOCK MARKET
These small-cap stocks might make you the most money in 2023, based on two important data points
by userby user[ad_1] Small-cap stocks are trading near a two-decade low relative to large-cap stocks. When the…
-
STOCK MARKET
More risk doesn’t always mean greater reward. Just look at these imploded tech stocks.
by userby user[ad_1] Academic critics have long argued that U.S. companies need to make more “creative-destruction” investments…
-
STOCK MARKET
Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a ‘cash-burning inferno’
by userby user[ad_1] Twist Bioscience Corp.’s stock slid 20% Tuesday, after a blistering short-seller report compared the…
-
[ad_1] AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a…